Marc Tessier-Lavigne Insider Trading $DNA GENENTECH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Tessier-Lavigne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Tessier-Lavigne. Marc Tessier-Lavigne is EVP, RESEARCH DRUG DISCOVERY in GENENTECH INC ($DNA) and Director in PFIZER INC ($PFE) and Director in REGENERON PHARMACEUTICALS INC ($REGN) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Denali Therapeutics Inc. ($DNLI).
Marc Tessier-Lavigne in GENENTECH INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: EVP, RESEARCH DRUG DISCOVERY
Holdings: 0 shares
Latest Transaction: Mar 30 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Marc Tessier-Lavigne in GENENTECH INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, DNLI, DNA, JUNO, PFE, REGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 85.83 | 75,000 | 6,437,250 | 0 | |
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 79.55 | 57,000 | 4,534,350 | 0 | |
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 79.17 | 72,000 | 5,700,240 | 0 | |
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 73.47 | 55,000 | 4,040,850 | 0 | |
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | D | 53.23 | 5,625 | 299,419 | 0 | |
| Mar 30 2009 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Sell | D | 95.00 | 1,159 | 110,105 | 0 | 1.2 K to 0 (-100.00 %) |
| Jul 18 2008 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Option Exercise | M | 53.23 | 18,750 | 998,063 | 5,625 | |
| Jul 18 2008 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Sell | S | 79.90 | 18,750 | 1,498,125 | 1,159 | 19.9 K to 1.2 K (-94.18 %) |
| Jul 18 2008 | DNA | GENENTECH INC | Tessier-Lavigne Marc | EVP, RESEARCH DRUG ... | Buy | M | 53.23 | 18,750 | 998,063 | 19,909 | 1.2 K to 19.9 K (+1,617.77 %) |
Page: 1